On October 16, DUALITYBIO-B rose 5.81% in Regular Trading, trading at HK$165.2, with turnover of HK$21.01 million.
The main catalyst in public disclosures was the company’s second straight day of share repurchases, which the market read as a supportive capital-management signal.
On October 15, the company repurchased 30,000 shares on the Hong Kong exchange at HK$152.4 to HK$167.5 per share, spending about HK$4.83 million, with the shares to be held in treasury. Combined with the 21,000 shares repurchased on October 14 for about HK$3.48 million, total buybacks over two days reached 51,000 shares. The same latest filing also showed 9,000 new shares were issued, while issued share capital changed to 91,388,297 shares and treasury shares increased to 451,100. Recent market attention has also remained on its planned STAR Market fundraising and related inquiries, so the buybacks appear to have provided near-term support rather than fully resetting the broader debate on funding and cash burn.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments